About
Catalent
Catalent’s Strathroy facility at 720 Wright Street provides specialized softgel development and manufacturing for pharmaceutical, over-the-counter, and consumer health products. One of two Catalent sites in Canada with softgel capabilities, the 110,000-square-foot operation brings formulation, commercial manufacturing, analytical testing, and packaging together to support projects from development through market launch. Its capabilities include prescription and OTC softgels, supported by quality-control laboratories and Catalent’s RP Scherer® technology. The facility is FDA-approved and licensed by Health Canada as a Canadian Natural Health Product site.